Enfusion, Inc.·4

Nov 16, 8:30 PM ET

Groman Dan 4

4 · Enfusion, Inc. · Filed Nov 16, 2023

Insider Transaction Report

Form 4
Period: 2023-11-14
Groman Dan
Chief Technology Officer
Transactions
  • Sale

    Class A Common Stock

    2023-11-14$9.97/sh5,000$49,850133,828 total
Footnotes (2)
  • [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.83 to $10.19. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.

Documents

1 file
  • 4
    tm2330951-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT